However, stringent government regulations on pharma blister packaging is expected to restrain growth of the global market. For instance, the U.S. government has prescribed stringent set of specification under regulation US 21 CFR and USP 34 NF 29 for controlling the quality of packaging material. Therefore these stringent norms are expected to hinder the market growth.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients